Analyst Price Targets — NUVL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 24, 2026 9:04 am | — | Bernstein | $124.00 | $123.44 | TheFly | Nuvalent downgraded to Market Perform from Outperform at Bernstein |
| June 10, 2026 11:01 am | Brad Canino | Guggenheim | $124.00 | $123.25 | TheFly | Nuvalent downgraded to Neutral from Buy at Guggenheim |
| June 10, 2026 6:53 am | David Dai | UBS | $124.00 | $123.25 | StreetInsider | UBS Downgrades Nuvalent (NUVL) to Neutral |
| June 9, 2026 8:35 pm | — | Truist Financial | $124.00 | $123.25 | TheFly | Nuvalent downgraded to Hold from Buy at Truist |
| June 9, 2026 5:14 pm | — | Barclays | $124.00 | $123.16 | TheFly | Nuvalent downgraded to Equal Weight from Overweight at Barclays |
| June 9, 2026 3:13 pm | — | Robert W. Baird | $122.85 | $123.13 | TheFly | Nuvalent downgraded to Neutral from Outperform at Baird |
| June 9, 2026 2:22 pm | — | Stifel Nicolaus | $124.00 | $123.20 | TheFly | Nuvalent downgraded to Hold from Buy at Stifel |
| June 9, 2026 1:07 pm | Eva Fortea Verdejo | Wells Fargo | $124.00 | $122.88 | TheFly | Nuvalent downgraded to Equal Weight from Overweight at Wells Fargo |
| June 9, 2026 1:06 pm | — | H.C. Wainwright | $124.00 | $122.85 | TheFly | Nuvalent downgraded to Neutral from Buy at H.C. Wainwright |
| June 9, 2026 12:24 pm | — | Piper Sandler | $124.00 | $122.88 | TheFly | Nuvalent downgraded to Neutral from Overweight at Piper Sandler |
Latest News for NUVL
BALA CYNWYD, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propo
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nuvalent, Inc. (NasdaqGS: NUVL) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of Nuvalent will receive $124.00 in cash for each share of Nuvalent that they own. KSF is seeking to…
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc.
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NUVL.
U.S. House Trading
No House trades found for NUVL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.